Drug Profile
Research programme: human monoclonal antibodies - Medarex/Abbott Laboratories
Alternative Names: Human monoclonal antibodies research programme - Medarex/Abbott LaboratoriesLatest Information Update: 06 Mar 2008
Price :
$50
*
At a glance
- Originator Abbott Laboratories; Medarex
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Immunological disorders
Most Recent Events
- 29 Jun 2005 This programme is still in active development
- 30 Jan 2003 Preclinical trials in Immunological disorders in USA (unspecified route)